Holen Sie sich die Stockscreener-App
4.57
2.24%
0.10
Handel nachbörslich:
4.57
Schlusskurs vom Vortag:
$4.47
Offen:
$4.53
24-Stunden-Volumen:
94,395
Relative Volume:
0.05
Marktkapitalisierung:
$20.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.69M
KGV:
-1.9614
EPS:
-2.33
Netto-Cashflow:
$-3.81M
1W Leistung:
+2.70%
1M Leistung:
+4.34%
6M Leistung:
+280.83%
1J Leistung:
+122.93%
1-Tages-Spanne:
$4.3977
$4.80
1-Wochen-Bereich:
$4.021
$4.85
52-Wochen-Spanne:
$0.64
$5.14
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Firmenname
Lixte Biotechnology Holdings Inc
Sektor
Branche
Telefon
310 203 2902
Adresse
248 ROUTE 25A, EAST SETAUKET
Vergleichen Sie LIXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.57 | 20.39M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Certain Options of Lixte Biotechnology Holdings, Inc. are subject to a Lock-Up Agreement Ending on 7-SEP-2025. - MarketScreener
Will Lixte Biotechnology Holdings Inc. stock recover after recent dropJuly 2025 Short Interest & Growth Focused Investment Plans - Newser
Key resistance and support levels for Lixte Biotechnology Holdings Inc. Equity Warrant2025 Market Outlook & Verified Swing Trading Watchlist - Newser
Aug Closing: Will Lixte Biotechnology Holdings Inc. stock hit new highs in YEARJuly 2025 Highlights & Reliable Volume Spike Alerts - خودرو بانک
Can Lixte Biotechnology Holdings Inc. Equity Warrant sustain its profitabilityWeekly Investment Recap & Risk Controlled Stock Alerts - خودرو بانک
Lixte Biotechnology Holdings Inc. stock trend outlook and recovery pathTrade Entry Report & Long-Term Investment Growth Plans - Newser
Does Lixte Biotechnology Holdings Inc. meet Warren Buffett’s criteriaEarnings Growth Report & Step-by-Step Trade Execution Guides - خودرو بانک
Institutional Tools Highlight Unusual Flow in Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Chart Watch & High Accuracy Investment Signals - beatles.ru
Does Lixte Biotechnology Holdings Inc. have declining or rising EPSDay Trade & Verified Chart Pattern Trade Signals - خودرو بانک
Using economic indicators to assess Lixte Biotechnology Holdings Inc. Equity Warrant potentialBond Market & Fast Entry and Exit Trade Plans - Newser
Is Lixte Biotechnology Holdings Inc. still a buy after recent gainsWeekly Trade Review & Free Risk Controlled Daily Trade Plans - خودرو بانک
What the charts say about Lixte Biotechnology Holdings Inc. todayJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - Newser
Is Lixte Biotechnology Holdings Inc. stock entering bullish territoryJuly 2025 Technicals & Community Supported Trade Ideas - Newser
Tools to assess Lixte Biotechnology Holdings Inc. Equity Warrant’s risk profile2025 Market Outlook & Risk Managed Investment Signals - Newser
Is Lixte Biotechnology Holdings Inc. Equity Warrant benefiting from interest rate changesJuly 2025 Snapshot & Stock Portfolio Risk Management - خودرو بانک
What moving averages say about Lixte Biotechnology Holdings Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A Inhibitor - TradingView
Lixte Biotechnology Holdings Inc. Equity Warrant’s volatility index tracking explainedJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser
Why Lixte Biotechnology Holdings Inc. is moving todayJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Analyzing net buyer seller activity in Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Action & AI Enhanced Trading Signals - Newser
Short interest data insights for Lixte Biotechnology Holdings Inc.July 2025 Retail & Reliable Price Breakout Alerts - Newser
Will Lixte Biotechnology Holdings Inc. price bounce be sustainable2025 Price Momentum & Verified Trade Idea Suggestions - Newser
Is Lixte Biotechnology Holdings Inc. a top pick in the sector2025 Trading Volume Trends & Accurate Buy Signal Notifications - خودرو بانک
Published on: 2025-09-05 21:56:52 - خودرو بانک
Does Lixte Biotechnology Holdings Inc. Equity Warrant have declining or rising EPSDividend Hike & Low Volatility Stock Recommendations - خودرو بانک
Using Bollinger Bands to evaluate Lixte Biotechnology Holdings Inc.July 2025 Selloffs & AI Forecast for Swing Trade Picks - Newser
Applying Wyckoff theory to Lixte Biotechnology Holdings Inc. Equity Warrant stock2025 Price Action Summary & Safe Entry Zone Tips - Newser
What’s next for Lixte Biotechnology Holdings Inc. Equity Warrant stock priceJuly 2025 Sector Moves & Reliable Breakout Forecasts - Newser
What MACD and RSI say about Lixte Biotechnology Holdings Inc.July 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Is it time to cut losses on Lixte Biotechnology Holdings Inc. Equity WarrantQuarterly Trade Review & Breakout Confirmation Trade Signals - Newser
Will Lixte Biotechnology Holdings Inc. stock hit new highs in YEARQuarterly Growth Report & Free Daily Entry Point Trade Alerts - khodrobank.com
Will Lixte Biotechnology Holdings Inc. stock recover after earningsTrade Risk Assessment & Real-Time Stock Entry Alerts - خودرو بانک
What is the Moat Score of Lixte Biotechnology Holdings Inc.Quarterly Growth Report & Short-Term High Return Ideas - خودرو بانک
Will Lixte Biotechnology Holdings Inc. Equity Warrant see short term momentumJuly 2025 Retail & Capital Efficiency Focused Ideas - Newser
Lixte Biotechnology Appoints New CFO and Board Members - TipRanks
Using AI based signals to follow Lixte Biotechnology Holdings Inc.2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
Lixte Biotechnology appoints new CFO and board members - MSN
Can Lixte Biotechnology Holdings Inc. recover in the next quarter2025 Short Interest & Capital Efficiency Focused Ideas - Newser
Candlestick signals on Lixte Biotechnology Holdings Inc. Equity Warrant stock today2025 Trading Volume Trends & Weekly High Potential Alerts - Newser
Will Lixte Biotechnology Holdings Inc. Equity Warrant stock hit new highs in YEAR - خودرو بانک
What’s the recovery path for long term holders of Lixte Biotechnology Holdings Inc.Earnings Recap Report & Daily Oversold Stock Bounce Ideas - Newser
Is Lixte Biotechnology Holdings Inc. stock ready for a breakoutIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Is Lixte Biotechnology Holdings Inc. affected by consumer sentimentQuarterly Market Review & Safe Capital Preservation Plans - خودرو بانک
Aug Mood: Is Lixte Biotechnology Holdings Inc. forming a bullish divergencePortfolio Value Summary & Weekly Return Optimization Plans - خودرو بانک
What indicators show strength in Lixte Biotechnology Holdings Inc. Equity WarrantPortfolio Growth Summary & Growth-Oriented Investment Plans - Newser
How high can Lixte Biotechnology Holdings Inc. Equity Warrant stock goJuly 2025 Recap & Low Risk Growth Stock Ideas - Newser
Published on: 2025-09-03 23:04:40 - Newser
Order flow analysis tools used on Lixte Biotechnology Holdings Inc. Equity WarrantTrade Signal Summary & Weekly High Conviction Trade Ideas - Newser
What institutional flow reveals about Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Breakouts & Verified High Yield Trade Plans - Newser
What machine learning models say about Lixte Biotechnology Holdings Inc.Weekly Market Report & Safe Entry Point Alerts - Newser
Will Lixte Biotechnology Holdings Inc. Equity Warrant outperform during market ralliesProduct Launch & Smart Allocation Stock Reports - خودرو بانک
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):